CRM
Neutral signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Unavailable or mixed. Purchase and sale value are mixed
- Congress Supports a bullish reading. 9 purchase disclosures year to date
- Financial indicators Unavailable or mixed. Current ratio 0.76 · operating margin 21% — readings disagree
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Unavailable or mixed. Weekly bias is flat
ACHAT TOTAL: 4 176 titres (~999 450,85 $ US) VENTE TOTALE: 4 500 titres (~1 172 231,10 $ US)
- Insiders
- Kirk David BlairConway Craig
- Total bought
-
$999,451
Avg buy (VWAP, 90d window) $239.33 vs last close $234.02 (-2.2%)
- Total sold
-
$1,172,231
Avg sell (VWAP, 90d window) $260.66 vs last close $234.02 (-10.2%)
- Last activity
- 2026-09-18
- Liquidity
- Liquid $3,417,795,943/day · 20d vol
- Last synced
-
2026-09-25 21:10:18
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-18 | Kirk David Blair | Buy | 4,176 | $239.33 | $999,451 | Form 4 |
| 2026-09-04 | Conway Craig | Sell | 3,082 | $260.66 | $803,363 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Neutral signalScored 2026-09-24
Salesforce shows genuinely improving fundamentals with strong margin expansion and operational efficiency gains, but the weak catalyst score (25/NONE) with low directional conviction means there is no near-term…
The first sentence of the analysis written for CRM on 2026-09-24 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 77.7% | 77.2% | 75.5% | 73.3% | 73.5% | |
| Ebit Margin | 22.9% | 20.2% | 17.2% | 5.9% | 6.6% | |
| Ebitda Margin | 31.7% | 29.4% | 26.5% | 18.0% | 19.1% | |
| Operating Profit Margin | 21.5% | 19.0% | 14.4% | 3.3% | 2.1% | |
| Pretax Profit Margin | 22.9% | 19.6% | 14.2% | 2.1% | 5.8% | |
| Continuous Operations Profit Margin | 18.0% | 16.4% | 11.9% | 0.7% | 5.5% | |
| Net Profit Margin | 18.0% | 16.4% | 11.9% | 0.7% | 5.5% | |
| Bottom Line Profit Margin | 18.0% | 16.4% | 11.9% | 0.7% | 5.5% | |
| Current Ratio | 0.760 | 1.062 | 1.092 | 1.019 | 1.049 | |
| Quick Ratio | 0.760 | 1.062 | 1.092 | 1.019 | 1.049 | |
| Solvency Ratio | 0.209 | 0.232 | 0.183 | 0.099 | 0.128 | |
| Cash Ratio | 0.197 | 0.316 | 0.318 | 0.271 | 0.251 | |
| Price To Earnings Ratio | 27.043 | 53.059 | 66.139 | 799.857 | 154.060 | |
| Price To Earnings Growth Ratio | 1.235 | 1.030 | 0.034 | -9.291 | -2.324 | |
| Forward Price To Earnings Growth Ratio | 1.235 | 1.030 | 0.034 | -9.291 | -2.324 | |
| Price To Earnings Diluted Ratio | 27.217 | 53.726 | 66.926 | 799.857 | 157.182 | |
| Price To Earnings Diluted Growth Ratio | 1.202 | 1.045 | 0.035 | -9.321 | -2.374 | |
| Price To Book Ratio | 3.410 | 5.374 | 4.590 | 2.855 | 3.822 | |
| Price To Sales Ratio | 4.857 | 8.674 | 7.854 | 5.315 | 8.386 | |
| Price To Free Cash Flow Ratio | 14.003 | 26.437 | 28.825 | 26.394 | 42.052 | |
| Price To Operating Cash Flow Ratio | 13.449 | 25.108 | 26.752 | 23.432 | 37.027 | |
| Debt To Assets Ratio | 0.153 | 0.111 | 0.126 | 0.143 | 0.147 | |
| Debt To Equity Ratio | 0.290 | 0.186 | 0.211 | 0.241 | 0.241 | |
| Debt To Capital Ratio | 0.225 | 0.157 | 0.174 | 0.194 | 0.194 | |
| Long Term Debt To Capital Ratio | 0.150 | 0.121 | 0.124 | 0.139 | 0.154 | |
| Financial Leverage Ratio | 1.899 | 1.683 | 1.674 | 1.694 | 1.638 | |
| Working Capital Turnover Ratio | -11.617 | 18.088 | 23.656 | 40.041 | 10.144 | |
| Operating Cash Flow Ratio | 0.404 | 0.468 | 0.384 | 0.275 | 0.275 | |
| Operating Cash Flow Sales Ratio | 0.361 | 0.345 | 0.294 | 0.227 | 0.226 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.960 | 0.950 | 0.928 | 0.888 | 0.880 | |
| Debt Service Coverage Ratio | 2.564 | 36.404 | 8.415 | 3.534 | 22.152 | |
| Interest Coverage Ratio | 27.522 | 26.489 | 0.000 | 3.589 | 2.491 | |
| Short Term Operating Cash Flow Coverage Ratio | 3.749 | 0.000 | 10.244 | 6.016 | 1,500.000 | |
| Operating Cash Flow Coverage Ratio | 0.873 | 1.149 | 0.813 | 0.505 | 0.429 | |
| Capital Expenditure Coverage Ratio | 25.246 | 19.897 | 13.905 | 8.911 | 8.368 | |
| Dividend Paid And Capex Coverage Ratio | 6.876 | 5.964 | 13.905 | 8.911 | 8.368 | |
| Dividend Payout Ratio | 0.213 | 0.248 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 16.084 | 29.728 | 30.137 | 30.776 | 45.680 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 77.7% | ▲0.5% | ▲2.2% |
| Ebit Margin | 22.9% | ▲2.7% | ▲8.3% |
| Ebitda Margin | 31.7% | ▲2.3% | ▲6.8% |
| Operating Profit Margin | 21.5% | ▲2.5% | ▲9.4% |
| Pretax Profit Margin | 22.9% | ▲3.3% | ▲10.0% |
| Continuous Operations Profit Margin | 18.0% | ▲1.6% | ▲7.5% |
| Net Profit Margin | 18.0% | ▲1.6% | ▲7.5% |
| Bottom Line Profit Margin | 18.0% | ▲1.6% | ▲7.5% |
| Current Ratio | 0.760 | ▼-0.302 | ▼-0.236 |
| Quick Ratio | 0.760 | ▼-0.302 | ▼-0.236 |
| Solvency Ratio | 0.209 | ▼-0.023 | ▲0.039 |
| Cash Ratio | 0.197 | ▼-0.119 | ▼-0.073 |
| Price To Earnings Ratio | 27.043 | ▼-26.016 | ▼-192.988 |
| Price To Earnings Growth Ratio | 1.235 | ▲0.205 | ▲3.098 |
| Forward Price To Earnings Growth Ratio | 1.235 | ▲0.205 | ▲3.098 |
| Price To Earnings Diluted Ratio | 27.217 | ▼-26.510 | ▼-193.765 |
| Price To Earnings Diluted Growth Ratio | 1.202 | ▲0.157 | ▲3.085 |
| Price To Book Ratio | 3.410 | ▼-1.964 | ▼-0.600 |
| Price To Sales Ratio | 4.857 | ▼-3.818 | ▼-2.160 |
| Price To Free Cash Flow Ratio | 14.003 | ▼-12.434 | ▼-13.539 |
| Price To Operating Cash Flow Ratio | 13.449 | ▼-11.659 | ▼-11.705 |
| Debt To Assets Ratio | 0.153 | ▲0.042 | ▲0.017 |
| Debt To Equity Ratio | 0.290 | ▲0.104 | ▲0.057 |
| Debt To Capital Ratio | 0.225 | ▲0.068 | ▲0.036 |
| Long Term Debt To Capital Ratio | 0.150 | ▲0.029 | ▲0.012 |
| Financial Leverage Ratio | 1.899 | ▲0.216 | ▲0.182 |
| Working Capital Turnover Ratio | -11.617 | ▼-29.705 | ▼-27.680 |
| Operating Cash Flow Ratio | 0.404 | ▼-0.064 | ▲0.043 |
| Operating Cash Flow Sales Ratio | 0.361 | ▲0.016 | ▲0.070 |
| Free Cash Flow Operating Cash Flow Ratio | 0.960 | ▲0.011 | ▲0.039 |
| Debt Service Coverage Ratio | 2.564 | ▼-33.840 | ▼-12.050 |
| Interest Coverage Ratio | 27.522 | ▲1.033 | ▲15.504 |
| Short Term Operating Cash Flow Coverage Ratio | 3.749 | ▲3.749 | ▼-300.253 |
| Operating Cash Flow Coverage Ratio | 0.873 | ▼-0.276 | ▲0.119 |
| Capital Expenditure Coverage Ratio | 25.246 | ▲5.349 | ▲9.980 |
| Dividend Paid And Capex Coverage Ratio | 6.876 | ▲0.911 | ▼-1.929 |
| Dividend Payout Ratio | 0.213 | ▼-0.035 | ▲0.121 |
| Enterprise Value Multiple | 16.084 | ▼-13.644 | ▼-14.397 |
Key metrics
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Market cap | $201.68B | $328.72B | $273.78B | $166.63B | $222.16B | |
| Enterprise value | $211.52B | $331.26B | $277.90B | $173.70B | $230.68B | |
| EV / Sales | 5.09x | 8.74x | 7.97x | 5.54x | 8.71x | |
| EV / Op. cash flow | 14.11x | 25.30x | 27.15x | 24.43x | 38.45x | |
| EV / Free cash flow | 14.69x | 26.64x | 29.26x | 27.51x | 43.66x | |
| EV / EBITDA | 16.08x | 29.73x | 30.14x | 30.78x | 45.68x | |
| Net debt / EBITDA | 0.75x | 0.23x | 0.45x | 1.25x | 1.69x | |
| Current ratio | 0.76x | 1.06x | 1.09x | 1.02x | 1.05x | |
| Income quality | 2.01x | 2.11x | 2.47x | 34.19x | 4.16x | |
| Graham number | $105 | $96 | $76 | $17 | $46 | |
| Graham net-net | -$35 | -$20 | -$18 | -$20 | -$20 | |
| Tax burden | 78.3% | 83.3% | 83.6% | 31.5% | 94.3% | |
| Interest burden | 100.0% | 97.0% | 82.5% | 35.5% | 87.4% | |
| Working capital | -$8.90B | $1.75B | $2.44B | $504.0M | $1.06B | |
| Invested capital | $60.98B | $62.85B | $62.40B | $62.79B | $63.67B | |
| Return on assets | 6.6% | 6.0% | 4.1% | 0.2% | 1.5% | |
| Operating ROA | 8.3% | 7.1% | 5.0% | 1.1% | 0.7% | |
| Return on tangible assets | 15.7% | 13.1% | 9.0% | 0.5% | 3.8% | |
| Return on equity | 12.6% | 10.1% | 6.9% | 0.4% | 2.5% | |
| Return on invested capital | 8.8% | 7.9% | 5.6% | 0.4% | 0.7% | |
| Return on capital employed | 11.9% | 9.6% | 6.8% | 1.4% | 0.7% | |
| Earnings yield | 3.7% | 1.9% | 1.5% | 0.1% | 0.6% | |
| Free cash flow yield | 7.1% | 3.8% | 3.5% | 3.8% | 2.4% | |
| Capex / Op. cash flow | 4.0% | 5.0% | 7.2% | 11.2% | 11.9% | |
| Capex / Depreciation | 16.4% | 18.9% | 18.6% | 21.1% | 21.7% | |
| Capex / Sales | 1.4% | 1.7% | 2.1% | 2.5% | 2.7% | |
| SG&A / Sales | 41.8% | 42.5% | 44.2% | 51.3% | 54.6% | |
| R&D / Sales | 14.4% | 14.5% | 14.1% | 16.1% | 16.9% | |
| Stock comp / Sales | 8.5% | 8.4% | 8.0% | 10.5% | 10.5% | |
| Intangibles / Total assets | 57.7% | 54.1% | 54.0% | 56.3% | 59.8% | |
| Days sales outstanding | 126d | 115d | 120d | 125d | 134d | |
| Days payables outstanding | 0d | 0d | 0d | 0d | 0d | |
| Operating cycle | 126d | 115d | 120d | 125d | 134d | |
| Cash conversion cycle | 126d | 115d | 120d | 125d | 134d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-38.6%EV / Sales ▼-41.7%EV / EBITDA ▼-45.9%EV / Op. cash flow ▼-11.197Earnings yield ▲+0.018Graham number ▲+8.854
Profitability
Return on equity ▲+0.025Return on assets ▲+0.006Return on invested capital ▲+0.008Return on capital employed ▲+0.022Operating ROA ▲+0.012Income quality ▼-0.102Tax burden ▼-0.050
Efficiency
Days sales outstanding ▲+10.985Days payables outstanding n/aOperating cycle ▲+10.985Cash conversion cycle ▲+10.985Capex / Sales ▼-0.003R&D / Sales ▼-0.001
Balance-sheet strength
Current ratio ▼-0.302Net debt / EBITDA ▲+0.521Working capital ▼-10643000000.000Invested capital ▼-1868000000.000Intangibles / Total assets ▲+0.035
Change over 5 years
Valuation
Market cap ▼-9.2%EV / Sales ▼-41.5%EV / EBITDA ▼-64.8%EV / Op. cash flow ▼-24.342Earnings yield ▲+0.030Graham number ▲+59.350
Profitability
Return on equity ▲+0.101Return on assets ▲+0.051Return on invested capital ▲+0.081Return on capital employed ▲+0.111Operating ROA ▲+0.076Income quality ▼-2.144Tax burden ▼-0.159
Efficiency
Days sales outstanding ▼-8.143Days payables outstanding n/aOperating cycle ▼-8.143Cash conversion cycle ▼-8.143Capex / Sales ▼-0.013R&D / Sales ▼-0.024
Balance-sheet strength
Current ratio ▼-0.288Net debt / EBITDA ▼-0.938Working capital ▼-9958000000.000Invested capital ▼-2689000000.000Intangibles / Total assets ▼-0.021
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
| Date | Member | Side | Amount range | Filing |
|---|---|---|---|---|
| 2026-08-14 | Tony Wied | Buy | $15,001 - $50,000 | Filing |
| 2026-08-10 | Ro Khanna | Buy | $1,001 - $15,000 | Filing |
| 2026-06-09 | Tony Wied | Buy | $15,001 - $50,000 | Filing |
| 2026-03-27 | Alan Armstrong | Buy | $1,001 - $15,000 | Filing |
| 2026-06-02 | Maria Elvira Salazar | Buy | $15,001 - $50,000 | Filing |
| 2026-06-02 | Maria Elvira Salazar | Buy | $15,001 - $50,000 | Filing |
| 2026-06-01 | Maria Elvira Salazar | Buy | $15,001 - $50,000 | Filing |
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-08-14 | Tony Wied | Purchase | $15,001 - $50,000 |
| 2026-08-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-07-14 | Tony Wied | Sale | $15,001 - $50,000 |
| 2026-07-07 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2026-06-09 | Tony Wied | Purchase | $15,001 - $50,000 |
| 2026-06-02 | Maria Elvira Salazar | Purchase | $15,001 - $50,000 |
| 2026-04-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-04-06 | Maria Elvira Salazar | Purchase | $15,001 - $50,000 |
| 2026-03-30 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2026-02-26 | David J. Taylor | Sale (Full) | $1,001 - $15,000 |
| 2026-02-26 | David J. Taylor | Sale (Full) | $15,001 - $50,000 |
| 2026-02-17 | Tony Wied | Sale | $15,001 - $50,000 |
| 2026-02-09 | David J. Taylor | Purchase | $1,001 - $15,000 |
| 2026-02-02 | Julia Letlow | Sale | $1,001 - $15,000 |
| 2026-01-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-01-29 | David J. Taylor | Purchase | $1,001 - $15,000 |
| 2025-12-16 | Julia Letlow | Sale (Full) | $1,001 - $15,000 |
| 2025-10-27 | Tony Wied | Purchase | $100,001 - $250,000 |
| 2025-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-09-23 | Val Hoyle | Sale (Full) | $1,001 - $15,000 |
| 2025-09-05 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2025-09-03 | David J. Taylor | Purchase | $1,001 - $15,000 |
| 2025-08-26 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2025-08-26 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2025-08-07 | David J. Taylor | Purchase | $1,001 - $15,000 |
| 2025-07-25 | Julia Letlow | Purchase | $1,001 - $15,000 |
| 2025-07-16 | Lisa C. McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-07-11 | Ritchie Torres | Sale (Full) | $1,001 - $15,000 |
| 2025-07-03 | James Comer | Sale (Partial) | $1,001 - $15,000 |
| 2025-06-26 | Val Hoyle | Purchase | $1,001 - $15,000 |
| 2025-06-17 | Lisa C. McClain | Purchase | $1,001 - $15,000 |
| 2025-06-11 | David J. Taylor | Purchase | $1,001 - $15,000 |
| 2025-06-04 | Josh S. Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 2025-05-22 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2025-05-12 | Jefferson Shreve | Sale (Full) | $15,001 - $50,000 |
| 2025-05-12 | David J. Taylor | Purchase | $1,001 - $15,000 |
| 2025-05-08 | Jefferson Shreve | Purchase | $15,001 - $50,000 |
| 2025-04-21 | Bruce Westerman | Sale (Full) | $1,001 - $15,000 |
| 2025-04-17 | Josh S. Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 2025-04-11 | Daniel Milton Newhouse | Sale (Partial) | $1,001 - $15,000 |
| 2025-04-07 | Julie Johnson | Sale (Full) | $1,001 - $15,000 |
| 2025-04-07 | Jefferson Shreve | Sale (Full) | $15,001 - $50,000 |
| 2025-03-27 | Greg Landsman | Sale (Full) | $15,001 - $50,000 |
| 2025-03-21 | Lisa C. McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-03-11 | Jonathan Jackson | Sale (Full) | $15,001 - $50,000 |
| 2025-03-03 | Bruce Westerman | Purchase | $1,001 - $15,000 |
| 2025-02-07 | Julia Letlow | Sale (Full) | $1,001 - $15,000 |
| 2025-01-29 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2025-01-21 | Robert P. Bresnahan | Sale (Full) | $15,001 - $50,000 |
| 2025-01-13 | Robert P. Bresnahan | Sale (Full) | $1,001 - $15,000 |
| 2024-12-13 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2024-12-11 | Lisa C. McClain | Purchase | $1,001 - $15,000 |
| 2024-12-06 | Julia Letlow | Sale (Partial) | $1,001 - $15,000 |
| 2024-11-14 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2024-11-13 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2024-11-12 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2024-10-28 | Jonathan Jackson | Purchase | $15,001 - $50,000 |
| 2024-10-23 | Julia Letlow | Purchase | $1,001 - $15,000 |
| 2024-10-14 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2024-09-26 | Ritchie Torres | Purchase | $1,001 - $15,000 |
| 2024-09-09 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-09-09 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-09-09 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2024-07-22 | Josh S. Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 2024-07-09 | Jonathan Jackson | Sale (Full) | $15,001 - $50,000 |
| 2024-07-02 | Kathy E. Manning | Purchase | $1,001 - $15,000 |
| 2024-06-26 | Josh S. Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2024-05-30 | Josh S. Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2024-04-10 | Daniel Milton Newhouse | Sale (Full) | $1,001 - $15,000 |
| 2024-03-20 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2024-03-13 | Josh S. Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2024-02-13 | Ro Khanna | Sale | $50,001 - $100,000 |
| 2024-01-23 | Kathy E. Manning | Purchase | $1,001 - $15,000 |
| 2024-01-23 | Kathy E. Manning | Purchase | $1,001 - $15,000 |
| 2024-01-23 | Kathy E. Manning | Purchase | $15,001 - $50,000 |
| 2023-12-04 | John R. Curtis | Sale (Full) | $1,001 - $15,000 |
| 2023-12-01 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2023-11-22 | Josh S. Gottheimer | Sale | $1,001 - $15,000 |
| 2023-11-08 | Josh S. Gottheimer | Sale | $1,001 - $15,000 |
| 2023-10-24 | Greg Stanton | Sale (Full) | $1,001 - $15,000 |
| 2023-10-18 | Greg Landsman | Sale (Full) | $1,001 - $15,000 |
| 2023-10-02 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-09-26 | Greg Stanton | Purchase | $1,001 - $15,000 |
| 2023-07-21 | Pete Sessions | Sale (Full) | $1,001 - $15,000 |
| 2023-06-26 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-06-09 | Jonathan Jackson | Purchase | $15,001 - $50,000 |
| 2023-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-04-24 | Greg Landsman | Purchase | $1,001 - $15,000 |
| 2023-04-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-03-14 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-03-06 | Daniel Goldman | Purchase | $15,001 - $50,000 |
| 2023-02-28 | Dwight Evans | Sale (Full) | $1,001 - $15,000 |
| 2023-01-31 | Daniel Goldman | Purchase | $100,001 - $250,000 |
| 2023-01-31 | Kevin Hern | Sale (Full) | $1,001 - $15,000 |
| 2023-01-13 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2023-01-12 | Greg Landsman | Purchase | $1,001 - $15,000 |
| 2023-01-11 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-01-09 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-12-20 | Nancy Pelosi | Sale (Full) | $0 - $1,000 |
| 2022-08-05 | Daniel Milton Newhouse | Purchase | $1,001 - $15,000 |
Recent news
- 2026-09-23 Enterprise Software Stocks Rally as Tech Tape Slides: Atlassian Corporation, Monday.com and Salesforce Climb 3%, ServiceNow Nudges Higher Enterprise software stocks are rising in Wednesday morning trading while the broader large-cap technology group falls. The iShares Expanded Tech-Software Sector ETF (NYSEARCA:IGV) is up 1%.
- 2026-09-23 "Decoding the Software Landscape:" Ways AI Disrupts Digital Companies Ben Topor, who recently published "Decoding the Software Landscape," discusses ways AI is disrupting the digital industries. He says it''s hard for larger companies like Salesforce (CRM) to adjust in the evolving landscape due to the volume of customers they have.
- 2026-09-23 Here''s Why Salesforce (CRM) is a Strong Momentum Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here''s why you should take advantage.
- 2026-09-23 The Street is Finally Going Bullish on Salesforce and I Keep Buying Wall Street spent all year convinced AI would hollow out Salesforce''s business model, and every time the stock dipped, one investor kept adding to the position anyway.
- 2026-09-23 Frontier AI Slowdown: Stocks and ETFs to Watch A potential AI slowdown could shift investor focus from capital-intensive chipmakers toward software, cybersecurity and established tech platforms.
- 2026-09-23 Salesforce Remains Down Over 12 Months: This Wall Street Firm Doubled Down On Its Belief That 70% Returns Await Investors Salesforce has bled out over 12 months while its enterprise software peers crater even harder, yet one Wall Street firm just planted a flag so far above current prices that it stands alone on the Street.
- 2026-09-23 Vault CRM Extends Market Leadershipas Another Top 20 Biopharma Chooses Veeva With 190 live customers and 14 top 20 biopharma commitments, Vault CRM is the fastest path to AI PLEASANTON, Calif., Sept. 23, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a new top 20 biopharma commitment, adding to recent selections by Amgen, Biogen, Eli Lilly and Company, and Regeneron.
- 2026-09-22 Marc Benioff says Salesforce''s investment in Anthropic was a plan B that could pay off in ‘tens of billions'' Marc Benioff said that OpenAI''s relationship with Microsoft prevented Salesforce from investing. Salesforce backed Anthropic and other AI startups instead.
- 2026-09-22 3 Big Tech Stocks With the Most Upside Right Now Wall Street has targets for Google, NVIDIA, and Salesforce, but one analyst thinks those numbers still leave serious money on the table heading into 2027.
- 2026-09-22 The AI Software Story Wall Street Is Underrating Salesforce''s agentic AI business is scaling at a pace that would make most enterprise software companies envious, yet the stock keeps getting priced like a relic from the CRM era.